Is diclofenac injection appropriate for a 14‑year‑old boy, and what are the recommended dosing and safety considerations?

Diclofenac Injection for a 14-Year-Old Boy

Diclofenac injection can be used in a 14-year-old boy for acute pain management, but safety and effectiveness in pediatric patients have not been formally established by the FDA, requiring careful consideration of dosing, indication, and monitoring.

FDA Approval Status and Key Warnings

The FDA label explicitly states: "Safety and effectiveness in pediatric patients have not been established" 1. This means diclofenac injection lacks formal pediatric approval, though this does not preclude its use when clinically appropriate.

Critical FDA warnings applicable to this age group include:

• Cardiovascular risk: NSAIDs may cause serious cardiovascular thrombotic events, myocardial infarction, and stroke 1
• Gastrointestinal risk: Serious GI adverse events including bleeding, ulceration, and perforation can occur at any time without warning 1
• Hepatotoxicity: Severe hepatic reactions including liver necrosis and fulminant hepatitis have been reported; transaminases should be monitored within 4-8 weeks of initiating treatment 1

Dosing Recommendations

Based on available pediatric evidence and guidelines:

For intramuscular injection:

• Dose: 0.5-1 mg/kg every 8 hours (maximum 50 mg per dose) 2
• A practical approach uses approximately 2 mg/kg as a single dose for acute pain/fever 3
• Maximum daily dose: 150 mg/day (equivalent to 4 × 50 mg doses in children) 4

For intravenous administration:

• Ketorolac (another injectable NSAID) is dosed at 0.5-1 mg/kg up to 30 mg for a single intraoperative dose in children 2
• Diclofenac IV dosing extrapolated from oral data suggests 0.3 mg/kg 5

Clinical Indications Where Use is Supported

Diclofenac injection is most appropriate for:

1. Postoperative pain management - Well-studied in children ≥1 year undergoing minor surgeries 6, 7
2. Acute febrile conditions - Single IM injection provides effective antipyresis with temperature reduction of 1.1°C within 69 minutes 3
3. Acute musculoskeletal pain - Soft tissue injuries, sprains (though topical formulations studied more extensively) 8

Safety Profile in Adolescents

Reassuring data:

• Serious adverse reactions occur in fewer than 0.24% of children treated for acute pain 7
• In a study of 14-year-olds, no serious side effects were observed during emergency department observation 3
• Types of adverse reactions are similar to adults but rare in short-term use 7

Key concerns to monitor:

• Bleeding risk: Diclofenac probably increases bleeding events compared to opioids (RR 3.06) 9, though perioperative bleeding requiring surgical intervention is not increased 7
• Nausea/vomiting: Less common than with opioids (RR 0.75) 9
• Renal function: Monitor in patients with dehydration or pre-existing renal impairment 1
• Hepatotoxicity: Inform patient/family of warning signs (nausea, fatigue, jaundice, dark urine) 1

Practical Algorithm for Use

Step 1: Assess appropriateness

• Age ≥12 years (better safety data)
• Acute pain or fever requiring parenteral treatment
• No contraindications: aspirin triad (asthma + rhinitis + nasal polyps), active GI bleeding, severe hepatic/renal impairment, perioperative CABG surgery 1

Step 2: Dosing

• IM injection: 0.5-1 mg/kg (maximum 50 mg) every 8 hours
• Use lowest effective dose for shortest duration
• Do not exceed 150 mg/day total

Step 3: Monitoring

• Immediate: Observe for anaphylactoid reactions (first 30-60 minutes)
• Short-term: Monitor pain relief, temperature reduction, bleeding, GI symptoms
• If used >48 hours: Consider hepatic transaminases, renal function

Step 4: Transition

• Switch to oral NSAIDs (ibuprofen 10 mg/kg every 8 hours or diclofenac 1 mg/kg every 8 hours) as soon as patient can tolerate oral intake 2

Common Pitfalls to Avoid

1. Avoid in tonsillectomy patients - Controversy exists regarding postoperative hemorrhage risk 6
2. Do not combine with aspirin - No additional benefit and increased adverse effects 1
3. Avoid prolonged use - Injection formulation is for acute management only; transition to oral or discontinue
4. Do not use in dehydrated patients - Increased nephrotoxicity risk 1
5. Caution in asthmatic children - Risk of bronchospasm, though rare; more research needed 7

Alternative Considerations

If diclofenac injection is unavailable or contraindicated:

• Ketorolac IV/IM: 0.5-1 mg/kg (max 30 mg single dose, 10 mg q6h maintenance for max 48 hours) 2
• Ibuprofen oral: 10 mg/kg every 8 hours - first-line for most acute pain/fever 2
• Acetaminophen: Should remain first-line for fever due to superior tolerability 6

10, 2, 1, 3, 5, 9, 6, 7